Recombinant p. vivax merozoite protein-1 p42 vaccine

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/30 (2006.01) A61K 39/015 (2006.01) A61K 47/42 (2006.01) A61P 33/06 (2006.01) C07K 14/445 (2006.01) C07K 16/20 (2006.01) C12N 5/10 (2006.01) C12N 15/85 (2006.01) C12P 21/02 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2443947

In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

La présente invention concerne l'expression et la purification d'un Plasmodium vivax (SalI) PvMSP-1 p42 recombinant. La méthode de l'invention permet de produire une protéine hautement purifiée qui conserve le repliement et la formation de liaison disulfure de la molécule native. Le PvMSP-1 p42 recombinant est utile en tant que réactif de diagnostic, et peut être utilisé pour la production d'anticorps ou comme vaccin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant p. vivax merozoite protein-1 p42 vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant p. vivax merozoite protein-1 p42 vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant p. vivax merozoite protein-1 p42 vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1779462

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.